Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis

Indian Journal of Medical Microbiology

Volumn 25, Issue 4, 2007, Pages 323-329

  Osman, H ^a   Gabr, O ^b   Lotfy, S ^b   Gabr, S ^b  

^a Mansoura University   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Antioxidant enzymes; Apoptosis; Malondialdehyde; Nitric oxide; Oxidative stress; Viral hepatitis

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; MALONALDEHYDE; NITRIC OXIDE; PROTEIN BCL 2; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CELL STRESS; CHRONIC HEPATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID PEROXIDATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY; VIRUS HEPATITIS;

EID: 37549026458     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.37333     Document Type: Article

References (24)

1. Rust C, Gores GJ. Apoptosis and liver disease. Am J Med 2000;108:567-74.
2. Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatitis C. J Viral Hepat 2003;10:335-42.
3. Patel T. Apoptosis in hepatic pathophysiology. Clin Liver Dis 2000;4:295-317.
4. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002;37:56-62.
5. Brown R. The bcl-2 family of proteins. Br Med Bull 1997;53:466-77.
6. Guzinska-Ustymowicz K, Famulski W, Stasiak-Barmuta A, Zalewski B, Sulkowska M. Correlation between colorectal cancer Bcl-2 expression and tumor clinicopathological variables. Rocz Acad Med Bialymst 2002;47:246-53.
7. Ishak KG, Bapitesta A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepathol 1995;22:696-9.
8. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 1995;41:892-6.
9. Srinivas D, Mani H, Crumpler C, Van Thiel DH. Daily interferon therapy for chronic hepatitis C: A report of a community practice experience. Hepatogastroenterology 2002;49:1053-7.
10. Vincent B. Physician updates: Liver function testes. Can Liver Found 2004;2:1-3.
11. Guo LL, Guo Y, Cao CA. Relationship between hepatitis C virus infection and expression of apoptosis-related gene bcl-2, bax and ICH-1 in hepatocellular carcinoma tissues. Di Yi Jun Yi Da Xue Bao 2002;22:797-9.
12. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003;34:1-10.
13. Hamazaki K, Gochi A, Matsubara N, Mori M, Orita K. Expression of Fas antigen and Bcl-2 protein in hepatocellular carcinoma. Acta Med Okayama 1995;49:227-30.
14. Toubi E, Kessel A, Goldstein L, Slobodin G, Sabo E, Shmuel Z, et al. Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: Association with liver disease severity. J Hepatol 2001;35:774-80.
15. Frommel TO, Yong S, Zarling EJ. Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: A novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Am J Gastroenterol 1999;94:178-82.
16. Terradillos O, Coste DL, Pollicino T, Neuveut C, Sitterlin D, Lecoeur H, et al. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Oncogene 2002;17:377-86.
17. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 1998;273:381-5.
18. Gabriel A, Ziolkowski A, Dziambor AP, Radlowski P, Kropczynski G. Bcl-2 antigen expression in patients with chronic hepatitis C and advanced fibrosis. Med Sci Monit 2001;7:181-4.
19. Higueras V, Raya A, Rodrigo JM, Serra MA, Romá J, Romero FJ. Interferon decreases serum lipid peroxidation products of hepatitis C patients. Free Radic Biol Med 1994;16:131-3.
20. Mansurova FK, Mutikhova KH, Olimova SO. Lipid peroxidation and anti-oxidative protection in patients with chronic type C hepatitis. Klin Med (Mosk) 2005;83:39-42.
21. Shuvalova EP, Antonova TV, Baranovskaia VB. The importance of the antioxidant protection systems of the blood in adaptation to the infectious process in viral hepatitis B. Ter Arkh 1991;63:47-9.
22. Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 2004;34:57-62.
23. Di Mascio P, Murphy ME, Sies H. Antioxidant defense systems: The role of the carotenoids, tocopherols and thiols. Am J Clin Nutr 1991;53:194S-200S.
24. Anderson ME. Glutathione and glutathione delivery compounds. Adv Pharmacol 1997;38:65-78.